RXRX vs BFC

Comparison between Recursion Pharmaceuticals Inc - Class A (RXRX, Company) and Bank First Corp (BFC, Company).

RXRX is from the Healthcare sector, while BFC is from the Financial Services sector.

5-Year PerformanceBFC has outperformed RXRX, delivering a return of +17.7% compared to -36.8%

RXRX vs BFC - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	RXRX(COMPANY)	BFC(COMPANY)
Market Cap	$1.61B	$1.61B
Max Drawdown	93.13%	82.02%
Sharpe Ratio	-0.46	0.86
5Y Beta	2.62	0.65
Industry	Biotechnology	Banks - Regional
P/E Ratio	-2.64	19.99
Forward P/E	N/A	5.81
PEG Ratio	N/A	3.78
Dividend Yield	N/A	1.28%
5Y Dividends CAGR	N/A	47.88%
5Y EPS CAGR	-10.03%	5.62%
Debt to Equity	0.00%	0.00%
Free Cash Flow Yield	-20.20%	1.87%
P/S Ratio	24.06	8.34
P/B Ratio	1.57	1.97

Market Cap

RXRX

$1.61B

Winner

BFC

$1.61B

Max Drawdown

RXRX

93.13%

Winner

BFC

82.02%

Sharpe Ratio

RXRX

-0.46

Winner

BFC

0.86

5Y Beta

RXRX

2.62

Winner

BFC

0.65

Industry

RXRX

Biotechnology

BFC

Banks - Regional

P/E Ratio

Winner

RXRX

-2.64

BFC

19.99

Forward P/E

RXRX

N/A

BFC

5.81

PEG Ratio

RXRX

N/A

BFC

3.78

Dividend Yield

RXRX

N/A

BFC

1.28%

5Y Dividends CAGR

RXRX

N/A

BFC

47.88%

5Y EPS CAGR

RXRX

-10.03%

Winner

BFC

5.62%

Debt to Equity

RXRX

0.00%

BFC

0.00%

Free Cash Flow Yield

RXRX

-20.20%

Winner

BFC

1.87%

P/S Ratio

RXRX

24.06

Winner

BFC

8.34

P/B Ratio

Winner

RXRX

1.57

BFC

1.97

RXRX vs BFC - Historical Returns

Returns include dividend reinvestment.

Period	RXRX	BFC
1 month	+0.00%	+0.60%
3 months	-4.26%	+8.16%
6 months	-27.25%	+8.10%
1 year	-39.07%	+27.40%
5 years(CAGR)	-36.78%	+17.73%
10 years(CAGR)	N/A	+20.11%
Max(CAGR)	-35.94%	+8.61%

RXRX

+0.00%

Winner

BFC

+0.60%

RXRX

-4.26%

Winner

BFC

+8.16%

RXRX

-27.25%

Winner

BFC

+8.10%

RXRX

-39.07%

Winner

BFC

+27.40%

5Y(CAGR)

RXRX

-36.78%

Winner

BFC

+17.73%

10Y(CAGR)

RXRX

N/A

BFC

+20.11%

Max(CAGR)

RXRX

-35.94%

Winner

BFC

+8.61%

RXRX vs BFC - Annual Returns (2002 - 2026)

Returns include dividend reinvestment.

Year	RXRX	BFC
2026	-25.00%	+20.79%
2025	-43.27%	+30.77%
2024	-31.51%	+16.13%
2023	+30.60%	-4.01%
2022	-57.24%	+30.94%
2021	-45.27%	+12.46%
2020	N/A	-5.91%
2019	N/A	+47.63%
2018	N/A	+5.70%
2017	N/A	+37.31%
2016	N/A	+27.13%
2015	N/A	+28.05%
2014	N/A	+21.22%
2013	N/A	+26.17%
2012	N/A	+17.36%
2011	N/A	+20.19%
2010	N/A	+35.47%
2009	N/A	-15.60%
2008	N/A	-19.26%
2007	N/A	-16.01%
2006	N/A	-7.54%
2005	N/A	+15.48%
2004	N/A	+1.64%
2003	N/A	+5.17%
2002	N/A	-48.21%

RXRX vs BFC Drawdown Comparison

The maximum drawdown for RXRX was -93.13%, occurring on Mar 30, 2026. This drawdown has not yet recovered.

The maximum drawdown for BFC was -82.02%, occurring on Feb 18, 2009. Recovery took 3198 trading sessions.

The current RXRX drawdown is -92.38%. The current BFC drawdown is -4.04%.

Rank	RXRX	BFC
#1	-93.13% Jul 13, 2021 - Mar 30, 2026	-82.02% Sep 13, 2002 - Jun 1, 2015
#2	-38.10% Apr 29, 2021 - Jun 17, 2021	-39.78% Jun 12, 2019 - Mar 8, 2021
#3	-10.54% Apr 16, 2021 - Apr 21, 2021	-32.75% Nov 25, 2022 - Oct 17, 2024
#4	-10.45% Jun 21, 2021 - Jul 6, 2021	-20.02% Apr 30, 2018 - Mar 7, 2019
#5	-8.29% Apr 21, 2021 - Apr 29, 2021	-14.17% Feb 9, 2026 - Mar 20, 2026
#6	N/A	-13.46% Dec 11, 2024 - Apr 21, 2025
#7	N/A	-12.65% Jul 23, 2025 - Oct 6, 2025
#8	N/A	-12.09% Mar 12, 2021 - Jun 24, 2022
#9	N/A	-11.75% Oct 14, 2025 - Dec 11, 2025
#10	N/A	-11.30% Dec 30, 2015 - May 3, 2016
#11	N/A	-11.07% Dec 11, 2025 - Jan 21, 2026
#12	N/A	-7.55% May 30, 2019 - Jun 11, 2019
#13	N/A	-7.23% Nov 25, 2015 - Dec 30, 2015
#14	N/A	-7.08% Aug 18, 2022 - Oct 21, 2022
#15	N/A	-7.07% Jun 24, 2015 - Nov 6, 2015

Correlation

Correlation between RXRX and BFC is -0.55 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.

-0.55

-101